Sitagliptin and Ventricular fibrillation - a phase IV clinical study of FDA data

Summary:

Ventricular fibrillation is reported as a side effect among people who take Sitagliptin (sitagliptin), especially for people who are female, 30-39 old, also take Empagliflozin, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Ventricular fibrillation when taking Sitagliptin. It is created by eHealthMe based on reports of 3,929 people who have side effects when taking Sitagliptin from the FDA, and is updated regularly.

What is Sitagliptin?

Sitagliptin has active ingredients of sitagliptin. eHealthMe is studying from 3,933 Sitagliptin users. Check the latest studies of Sitagliptin.

What is Ventricular fibrillation?

Ventricular fibrillation (abnormally irregular heart rhythm) is found to be associated with 1,099 drugs and 1,245 conditions by eHealthMe. Check the latest studies of Ventricular fibrillation.

On Jul, 05, 2026

3,929 people reported to have side effects when taking Sitagliptin.
Among them, 14 people (0.36%) have Ventricular fibrillation.

Could Sitagliptin cause Ventricular fibrillation?

Among these 14 people:

What is the gender of people who have Ventricular fibrillation when taking Sitagliptin? *

female: 100 %
male: 0.0 %

What is the age of people who have Ventricular fibrillation when taking Sitagliptin? *

What are other drugs people take besides Sitagliptin? *

What are other side effects people have besides Ventricular fibrillation? *

Eosinophilic Myocarditis (acute and fulminate congestive heart failure): 13 people, 92.86%
Cardiac Arrest: 13 people, 92.86%
Breathing - Slowed Or Stopped: 13 people, 92.86%
Pulmonary Embolism (blockage of the main artery of the lung): 12 people, 85.71%
Metabolic Acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body): 12 people, 85.71%
Hypotension (abnormally low blood pressure): 9 people, 64.29%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 7 people, 50.00%
Drug Level Increased: 5 people, 35.71%
Cerebral Infarction (less blood supply to brain resulting tissue damage): 3 people, 21.43%
Embolic Cerebral Infarction (brain stroke due to obstruction of an artery): 2 people, 14.29%

What are the existing conditions these people have? *

Type 2 Diabetes: 13 people, 92.86%
Multiple Myeloma (cancer of the plasma cells): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Sitagliptin and have Ventricular fibrillation?

- Check whether Ventricular fibrillation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Sitagliptin:

Sitagliptin (3,933 reports)

Browse all side effects of Sitagliptin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular fibrillation:

Ventricular fibrillation (1,099 drugs)

Browse all the conditions that are associated with Ventricular fibrillation:

Ventricular fibrillation (1,245 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin (the active ingredients of Sitagliptin) and Sitagliptin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.